BridgeMD
Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression
EU CTIS ID: 2024-514866-37-01
What this study is testing
Saftey evaluation of a tolerance induction protocol using immunomodulatory cell therapy following deceased donor liver transplantation
- Phase I and Phase II (Integrated)- Bioequivalence Study
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients with indication for deceased donor liver transplantation.
- All genders
- Adult patients, 18 years or above
- MELD score <20
- Bar score <9
- WBC >2.0 x10^9 Cells/L
You likely can't join if
- Recipients: Acute liver failure
- Recipients: Total trombosis of portal vein
- Recipients: Liver re-transplantation
- Recipients: Not fulfilling inclusion criteria's (shown above).
- Recipients: Female patients within child bearing age without proof of negative pregnancy test
- Recipients: Patient participating in other interventional study
See the full eligibility criteria
- Patients with indication for deceased donor liver transplantation.
- All genders
- Adult patients, 18 years or above
- MELD score <20
- Bar score <9
- WBC >2.0 x10^9 Cells/L
- Able to read and understand the meaning of the patient information and give written consent.
- Recipients: Acute liver failure
- Recipients: Total trombosis of portal vein
- Recipients: Liver re-transplantation
- Recipients: Not fulfilling inclusion criteria's (shown above).
- Recipients: Female patients within child bearing age without proof of negative pregnancy test
- Recipients: Patient participating in other interventional study
- Donors: DCD donor or Partial liver-graft
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.